In addition to FNDC3B, two other variants PRDM16 and TWIST1 recently associated with CAD risk play key roles in adipogenic transdifferentiation of WAT to BAT which highlights this pathway as relevant to disease risk and therapeutic exploration. This evidence concerns the gene TWIST1 and coronary artery disorder.